Caracciolo Anthony 4
4 · CytoDyn Inc. · Filed Jan 10, 2019
Insider Transaction Report
Form 4
CytoDyn Inc.CYDY
CARACCIOLO ANTHONY
Director
Transactions
- Disposition to Issuer
Stock Options (right to buy)
2019-01-10−100,000→ 0 totalExercise: $0.64Exp: 2019-05-29→ Common Stock (100,000 underlying) - Award
Stock Options (right to buy)
2019-01-10+100,000→ 100,000 totalExercise: $0.64Exp: 2024-05-29→ Common Stock (100,000 underlying) - Disposition to Issuer
Stock Options (right to buy)
2019-01-10−50,000→ 0 totalExercise: $0.66Exp: 2019-06-01→ Common Stock (50,000 underlying) - Award
Stock Options (right to buy)
2019-01-10+50,000→ 50,000 totalExercise: $0.66Exp: 2024-06-01→ Common Stock (50,000 underlying)
Footnotes (2)
- [F1]The reported transactions involve the amendment of certain outstanding options to extend the expiration date of each by a period of five years, resulting in (for purposes of Section 16 of the Exchange Act of 1934, as amended) the deemed cancellation of the "old" option and the grant of a replacement option. There have been no changes in the exercise prices of such options, which were all at or above the closing sale price of the issuer's common stock as of the date of the reported transactions.
- [F2]Such options were fully vested and exercisable as of the date of the reported transactions.